Lumida
/CCRN
⌘K
Cross Country Healthcare Inc

Cross Country Healthcare Inc

CCRN
$13.25USD+0.08%+0.01 today

MARKET CAP

428.1M

P/E (TTM)

FWD P/E

DAY RANGE

$13 – $13

52W RANGE

$7
$15

AI Summary

Stalk
StalkMedium

The stock is in a Stage 2 advancing phase under a strong parabola-driven rally, consolidating tightly above the rising 9/20 EMAs and the 200 DMA after a steep advance. However, overextension above EMAs and an elevated RSI warn against chasing current highs. Without a Lockout Rally override and given the pattern's vulnerability to abrupt reversal, execution should be deferred until shallow pullbacks into the rising EMAs offer a better entry opportunity.

  • IntelliFi platform has 5,500 users across 500 sites, boosting efficiency
  • Travel demand rose 20% since Q2 start, broad across specialties
  • Q3 revenue fell to $315M, down 7% QoQ and 29% YoY from travel drop
Full analysis →
STATEMENT·Income statement
USD · GAAP
METRICFY 2021FY 2022FY 2023FY 2024FY 2025TREND
Sales, Adj.$1.7B$2.8B$2.0B$1.3B$1.1B
YoY %+100.5%+67.2%-28.0%-33.5%-21.6%
P / Sales0.6x0.4x0.4x0.5x0.2x
EV / Sales0.9x0.5x0.5x0.5x0.3x
Gross Profit, Adj.$1.7B$2.8B$450.4M$274.3M$213.6M
YoY %+100.5%+67.2%-83.9%-39.1%-22.1%
Margin %100.0%100.0%22.3%20.4%20.3%
EV / Gross Profit0.9x0.5x2.3x2.5x1.3x
EBITDA, Adj.$153.9M$289.9M$134.4M$12.8M$10.6M
YoY %+494.3%+88.4%-53.6%-90.5%-17.2%
Margin %9.2%10.3%6.7%1.0%1.0%
EV / EBITDA9.6x5.2x7.6x54.4x26.4x
EBIT$139.3M$269.9M$112.7M$-16.9M$-84.4M
YoY %+1620.8%+93.7%-58.2%-115.0%-400.5%
Margin %8.3%9.6%5.6%-1.3%-8.0%
EV / EBIT10.6x5.6x9.1x-41.2x-3.3x
Net Income$132.0M$186.0M$72.6M$-14.6M$-94.9M
YoY %+1118.4%+40.9%-60.9%-120.0%-551.6%
Net Margin7.9%6.6%3.6%-1.1%-9.0%
EPS (GAAP)$3.53$4.95$2.05-$0.44-$2.93
YoY %+1080.6%+40.2%-58.6%-121.5%-565.9%